New Zealand Gazette – 1995 – No. 147

Page 4775

✨ Health and Tax Notices



14 DECEMBER NEW ZEALAND GAZETTE 4775

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Influenza virus A/Beijing/32/92 15 mcg, influenza virus A/Singapore/6/86 15 mcg, influenza virus B/Panama/45/90 15 mcg Vaccine, single dose vial Sachsisches Serumwerk GmbH, Dresden, Germany and SmithKline Biologicals, Rixensart, Belgium Fluarix
Haloperidol decanoate equivalent to 50 mg/mL haloperidol in 1 mL, 3 mL Depot injection David Bull Laboratories Limited, Mulgrave North, Victoria, Australia Halperidol Decanoate Oily Injection
Hydrochlorothiazide 12.5 mg, Losartan potassium 50 mg Tablet Du Pont Merck Pharmaceuticals Co., Garden City, New York, United States of America and Merck Sharp & Dohme Limited, Cramlington, Northumberland, England Hyzaar
Dextromethorphan hydrobromide 1.5 mg/mL in 100 mL, 200 mL Solution, Oral Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Robitussin Cough Control Syrup
Desflurane 100% in 240 mL Liquid, volatile for inhalation Ohmeda Caribe Inc., Guayama, Puerto Rico Suprane

Dated this 8th day of December 1995.

KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.

g08284

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Human albumin 4% w/v in 50 mL, 500 mL Solution for IV injection CSL Limited, Broadmeadows, Victoria, Australia Albumex 4

Note: This medicine may only be distributed, supplied or used under conditions to be imposed from time to time by the Director-General of Health.

Dated this 7th day of December 1995.

KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.

g08285

Psychologists Act 1981

Appointments to the Psychologists Board

Pursuant to section 3 (2) (h) of the Psychologists Act 1981, I hereby appoint

Patricia Anne Hanlen

to be a member of the Psychologists Board for a 3 year term of office commencing from the date of the notice of appointment advertised in the New Zealand Gazette, or such later date as may be specified in the notice.

Dated at Wellington this 6th day of December 1995.

HON. KATHERINE O’REGAN, Associate Minister of Health.

g08180

Inland Revenue

Tax Administration Act 1994

Notice of Product Ruling

  1. This is a notice of a product ruling made under section 91F of the Tax Administration Act 1994.

  2. Product ruling No. 95/10 was issued on 28 November 1995. It relates to the tax assessability of benefit to recipients of transaction fees not charged.

  3. A copy of the ruling may be obtained by writing to the Manager (Systems), Rulings Directorate, National Office, Inland Revenue, P.O. Box 2198, Wellington.

JEFFREY TYLER, Assistant General Manager (Adjudication and Rulings).

g08212

Special Determination [S3]:

This determination may be cited as “Special Determination [S3]: Interest Reduction for Dividend Eligible Period on Conversion of Specified Mandatory Convertible Notes”.

1. Explanation

(which does not form part of this determination).

Convertible Notes

(1) A Mandatory Conversion Convertible Note (“MCCN”) is a financial arrangement in which the holder of the Note provides money to a company, and the debt is discharged at a future date by the issue of shares in any company. Interest may be payable for the period between the issue of the Note and conversion into shares. Such payments are called Coupon Interest Payments.

Amounts Attributable to Excepted Financial Arrangement

(2) As a share is an excepted financial arrangement under section OB 1 of the Act, only the Coupon Interest Payments and amounts attributed to those payments by Determination G5C are usually regarded as income or expenditure for the purposes of calculating accrual income or expenditure.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa — PDF NZ Gazette 1995, No 147


NZLII — PDF NZ Gazette 1995, No 147




✨ LLM interpretation of page content

🏥 Consent to Distribution of New Medicines (continued from previous page)

🏥 Health & Social Welfare
8 December 1995
Medicines, Distribution, Vaccines, Injections, Solutions
  • KAREN O. POUTASI, Director-General of Health

🏥 Provisional Consent to Distribution of New Medicine

🏥 Health & Social Welfare
7 December 1995
Medicine, Distribution, Human Albumin, IV Injection
  • KAREN O. POUTASI, Director-General of Health

🏥 Appointments to the Psychologists Board

🏥 Health & Social Welfare
6 December 1995
Psychologists, Board Appointment
  • Patricia Anne Hanlen, Appointed to Psychologists Board

  • HON. KATHERINE O’REGAN, Associate Minister of Health

💰 Notice of Product Ruling

💰 Finance & Revenue
Tax, Product Ruling, Assessability
  • JEFFREY TYLER, Assistant General Manager (Adjudication and Rulings)

💰 Special Determination for Interest Reduction

💰 Finance & Revenue
Tax, Interest Reduction, Convertible Notes